Pharmaids Pharmaceuticals Ltd Reports Q3 and Nine Months Results for 2025 with Auditor's Review

Pharmaids Pharmaceuticals Ltd has released its unaudited quarterly standalone financial results for the quarter and nine months ended December 31, 2025. The results were reviewed by PPKG & Co Batgach, the independent auditor, in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The review was conducted to obtain moderate assurance as to whether the financial statements are free of material misstatement. The Statement is prepared in accordance with the Ind AS 34, prescribed under Section 133 of the Companies Act, 2013. The review report does not express an audit opinion but concludes that nothing has come to their attention that causes them to believe that the Statement is not free of material misstatement. The Statement includes the results of Adita Bio Sys Private Limited, Sirl Labvivo Diet Private Limited, and Spring Labs, all step-down subsidiaries of the company.